Design, synthesis and anticancer activity of piperazine hydroxamates and their histone deacetylase (HDAC) inhibitory activity

被引：50

作者：

Chetan, Bhadaliya ^{[1
]}

Bunha, Mahesh ^{[1
]}

Jagrat, Monika ^{[1
]}

Sinha, Barij Nayan ^{[1
]}

Saiko, Philipp ^{[1
]}

Graser, Geraldine ^{[2
]}

Szekeres, Thomas ^{[2
]}

Raman, Ganapathy ^{[3
]}

Rajendran, Praveen ^{[3
]}

Moorthy, Dhatchana ^{[3
]}

Basu, Arijit ^{[1
]}

Jayaprakash, Venkatesan ^{[1
]}

机构：

[1] Birla Inst Technol, Dept Pharmaceut Sci, Ranchi 835215, Jharkhand, India

[2] Gen Hosp Vienna Med Univ Vienna, Dept Med & Chem Lab Diagnost, A-1090 Vienna, Austria

[3] Orchid Res Labs Ltd, Madras 600119, Tamil Nadu, India

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 13期

关键词：

Histone deacetylase inhibitors; Piperazine linker; Hydroxamates; RR pharmacophore; ASSAY; AGENTS; PROLIFERATION;

D O I：

10.1016/j.bmcl.2010.05.020

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Six compounds were synthesized with piperazine in linker region and hydroxamate as Zinc Binding Group ( ZBG). They were screened against three cancer cell-lines (NCIH460; HCT116; U251). Compounds 5c and 5f with GI(50) value of 9.33 +/- 1.3 mu M and 12.03 +/- 4 mu M, respectively, were tested for their inhibitory potential on hHDAC8. Compound 5c had IC(50) of 33.67 mu M. Compounds were also screened for their anticancer activity against HL60 human promyelocytic leukemia cell line due to the presence of pharmacophoric features of RR inhibitors in them. Compound 5c had IC(50) of 0.6 mu M at 48 h. (c) 2010 Elsevier Ltd. All rights reserved.

引用

页码：3906 / 3910

页数：5

共 50 条

[1] Design, synthesis and anticancer activity of novel valproic acid conjugates with improved histone deacetylase (HDAC) inhibitory activity
Ibrahim, Tarek S.
Sheha, Taghreed A.
Abo-Dya, Nader E.
AlAwadh, Mohammed A.
Alhakamy, Nabil A.
Abdel-Samii, Zakaria K.
Panda, Siva S.
Abuo-Rahma, Gamal El-Din A.
Mohamed, Mamdouh F. A.
BIOORGANIC CHEMISTRY, 2020, 99
[2] Synthesis of sulfonamides and evaluation of their histone deacetylase (HDAC) activity
Oh, Seikwan
Moon, Hyung-In
Son, Il-Hong
Jung, Jae-Chul
MOLECULES, 2007, 12 (05) : 1125 - 1135
[3] Inhibitors of Human Histone Deacetylase: Synthesis and Enzyme Assay of Hydroxamates with Piperazine Linker
Chakrabarty, Shubhashis
Bhadaliya, Chetan
Sinha, Barij Nayan
Mahesh, Aruna
Bai, He
Blond, Sylvie Y.
Jayaprakash, Venkatesan
ARCHIV DER PHARMAZIE, 2010, 343 (03) : 167 - 172
[4] Design, Multicomponent Synthesis, and Anticancer Activity of a Focused Histone Deacetylase (HDAC) Inhibitor Library with Peptoid-Based Cap Groups
Krieger, Viktoria
Hamacher, Alexandra
Gertzen, Christoph G. W.
Senger, Johanna
Zwinderman, Martijn R. H.
Marek, Martin
Romier, Christophe
Dekker, Frank J.
Kurz, Thomas
Jung, Manfred
Gohlke, Holger
Kassack, Matthias U.
Hansen, Finn K.
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (13) : 5493 - 5506
[5] Synthesis of new β-lactam analogs and evaluation of their histone deacetylase (HDAC) activity
Oh, Seikwan
Jung, Jae-Chul
ZEITSCHRIFT FUR NATURFORSCHUNG SECTION B-A JOURNAL OF CHEMICAL SCIENCES, 2007, 62 (11): : 1459 - 1464
[6] Inhibitors of human histone deacetylase: Synthesis and enzyme and cellular activity of straight chain hydroxamates
Remiszewski, SW
Sambucetti, LC
Atadja, P
Bair, KW
Cornell, WD
Green, MA
Howell, KL
Jung, M
Kwon, P
Trogani, N
Walker, H
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (04) : 753 - 757
[7] Synthesis and histone deacetylase inhibitory activity of new benzamide derivatives
Suzuki, T
Ando, T
Tsuchiya, K
Fukazawa, N
Saito, A
Mariko, Y
Yamashita, T
Nakanishi, O
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (15) : 3001 - 3003
[8] Design, synthesis, biological evaluation and molecular docking study of arylcarboxamido piperidine and piperazine-based hydroxamates as potential HDAC8 inhibitors with promising anticancer activity
Trivedi, Prakruti
Adhikari, Nilanjan
Amin, Sk Abdul
Bobde, Yamini
Ganesh, Routholla
Jha, Tarun
Ghosh, Balaram
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 138
[9] Antitheilerial Activity of the Anticancer Histone Deacetylase Inhibitors
Barman, Madhumanti
Kamble, Sonam
Roy, Sonti
Bhandari, Vasundhra
Singothu, Siva
Dandasena, Debabrata
Suresh, Akash
Sharma, Paresh
FRONTIERS IN MICROBIOLOGY, 2021, 12
[10] Selective Histone Deacetylase Inhibitors with Anticancer Activity
Ma, Nan
Luo, Ying
Wang, Ying
Liao, Chenzhong
Ye, Wen-Cai
Jiang, Sheng
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2016, 16 (04) : 415 - 426

← 1 2 3 4 5 →